PHAT FY 2020 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$300,000

Operating Income

-$126M

Net Income

-$129M

EPS (Diluted)

$-4.01

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$71M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$295M

Total Liabilities

$101M

Stockholders' Equity

$194M

Cash & Equivalents

$287M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$300,000	-$8,000	-3650.0%
Operating Income	-$126M	-$106M	-18.3%
Net Income	-$129M	-$210M	+38.5%